Your session is about to expire
← Back to Search
Other
Study for Papulopustular Rosacea
N/A
Waitlist Available
Led By Peter Friedman, MD PhD
Research Sponsored by The Skin Center Dermatology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
Study Summary
This trial will test if a cold plasma device, used on one side of the face, is better than a cream for treating acne.
Eligible Conditions
- Papulopustular Rosacea
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Demodex count change
Efficacy - Investigator global assessment
Efficacy - National Rosace Society Expert Committee grading system
+1 moreSecondary outcome measures
Tolerability - Incidence of Treatment-Emergent Adverse Events as assessed by patient review
Tolerability - pain as assessed by NRS scale
Trial Design
1Treatment groups
Experimental Treatment
Group I: StudyExperimental Treatment1 Intervention
Single arm study: split face treatment
Find a Location
Who is running the clinical trial?
The Skin Center Dermatology GroupLead Sponsor
3 Previous Clinical Trials
157 Total Patients Enrolled
Peter Friedman, MD PhDPrincipal InvestigatorThe Skin Center Dermatology Group
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the cap on participants for this medical trial?
"Affirmative. Clinicaltrials.gov's records demonstrate that this clinical trial commenced on the 2nd of January 2023 and has since been updated on the 27th of October 2022. Currently, they are recruiting 10 individuals from one medical site."
Answered by AI
Are new participants still being accepted into this experiment?
"Yes, the information available on clinicaltrials.gov affirms that this medical trial is enlisting patients. The study was first submitted on February 1st 2023 and the data were last updated on October 27th 2022. Currently, 10 people need to be recruited from one single location."
Answered by AI
Share this study with friends
Copy Link
Messenger